Who is sponsoring NCT06110104?

NCT06110104 is sponsored by Marwa Gamal Abd El Ghany Fathalla.

What drugs are being tested in NCT06110104?

Interventions in NCT06110104: routine physiotherapy program for knee osteoarthritis, Retro-walking program, whole body vibration training.

What condition does NCT06110104 study?

NCT06110104 studies Knee Osteoarthritis.

Is NCT06110104 still recruiting?

NCT06110104 is currently completed. Last updated 31 October 2023.

Last reviewed 2023-10-31 · How we verify

NCT06110104

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Retrowalking Program Versus Whole Body Vibration in Patients With Chronic Knee Osteoarthritis

Completed NA Last updated 31 October 2023

What this trial tests

NA trial testing routine physiotherapy program for knee osteoarthritis in Knee Osteoarthritis in 45 participants. Completed in 23 September 2023.

Timeline

11 September 2023

Primary endpoint
11 September 2023

23 September 2023

Quick facts

Lead sponsor	Marwa Gamal Abd El Ghany Fathalla
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	45
Start date	11 September 2023
Primary completion	11 September 2023
Estimated completion	23 September 2023
Sites	1 location across Egypt

Drugs / interventions tested

routine physiotherapy program for knee osteoarthritis
Retro-walking program
whole body vibration training

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

Marwa Gamal Abd El Ghany Fathalla

Who can join

Adults 40 to 55, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Osteoarthritis is one of the most common degenerative joint disease that affects approximately more than 300 million people worldwide

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06110104 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marwa Gamal Abd El Ghany Fathalla
Last refreshed: 31 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06110104.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing